| Literature DB >> 28833739 |
Dokyoung Kim1,2, Jinyoung Kang3, Taejun Wang4, Hye Gun Ryu5, Jonathan M Zuidema6, Jinmyoung Joo7,8, Muwoong Kim1, Youngbuhm Huh1, Junyang Jung1, Kyo Han Ahn5, Ki Hean Kim9, Michael J Sailor10.
Abstract
A major obstacle in luminescence imaging is the limited penetration of visible light into tissues and interference associated with light scattering and autofluorescence. Near-infrared (NIR) emitters that can also be excited with NIR radiation via two-photon processes can mitigate these factors somewhat because they operate at wavelengths of 650-1000 nm where tissues are more transparent, light scattering is less efficient, and endogenous fluorophores are less likely to absorb. This study presents photolytically stable, NIR photoluminescent, porous silicon nanoparticles with a relatively high two-photon-absorption cross-section and a large emission quantum yield. Their ability to be targeted to tumor tissues in vivo using the iRGD targeting peptide is demonstrated, and the distribution of the nanoparticles with high spatial resolution is visualized.Entities:
Keywords: cancer diagnostics; iRGD targeting peptide; nanomedicine; photoluminescence
Year: 2017 PMID: 28833739 DOI: 10.1002/adma.201703309
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849